Article

Chase finalizes Unicorn acquisition, expands line

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients.

Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients. The combined company officially has launched its expanded set of patient financing products as ChaseHealthAdvance financing options.

Increasing medical and dental costs have created a need for new and adaptive health-care financing options, according to the company. In addition, the demand for elective procedures-dental, vision correction, and cosmetic, as well as veterinary care for pets-is increasing rapidly.

“Chase is able to offer affordable, flexible options for those looking to finance health-care procedures, as well as provide competitive service fees for providers,” said Hugh Bleemer, general manager, ChaseHealthAdvance.

Among the offerings to physicians and patients are no-interest and extended payment plans, as well as credit lines for current and future procedures, according to the company. In addition, medical practitioners will have access to all of Chase’s financial products, including business banking, real estate financing, equipment leasing, cash management, credit card processing, and loan products.

For more information on ChaseHealthAdvance financing options, visit www.chasehealthadvance.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.